LACHELLE ACHTERBERG: Open Payments
NPI 1427396290 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 17 payments from 10 companies in 2025. Trend: 2023 $45 · 2024 $81 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $211 |
| Novo Nordisk Inc | 3 | $48 |
| ABBVIE INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: BREZTRI, AIRSUPRA, UBRELVY, Wegovy, CAPLYTA, DIAMONDBACK CORONARY, Cologuard Collection Kit, XIFAXAN.
Industry payments across KY — which companies pay providers there.
